Batilona, Nilo T.

HRN: 23-01-18  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2023
CEFTRIAXONE 1G (VIAL)
05/07/2023
05/14/2023
IV
2g
OD
Acute Appendicitis
Waiting Final Action 
05/07/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/07/2023
05/14/2023
IV
500mg
Q8hrs
Acute Appendicitis
Waiting Final Action 
05/08/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/08/2023
05/08/2023
IV
4.5
LD
Sepsis
Waiting Final Action 
05/08/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/08/2023
05/15/2023
IV
2.25
Q6
Sepsis
Waiting Final Action 
05/12/2023
LEVOFLOXACIN 500MG (TAB)
05/12/2023
05/19/2023
NGT
750mg
OD
Sepsis
Waiting Final Action 
05/14/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/14/2023
05/21/2023
IV
4.5
Q8
Sepsis
Waiting Final Action 
05/18/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/18/2023
05/24/2023
IV
3.375g
Q6
CAP-HR
Waiting Final Action 
05/18/2023
LEVOFLOXACIN 500MG (TAB)
05/18/2023
05/20/2023
PO
250mg
OD
CAP-HR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: